Begin main content

Reports

We found 6186 result(s)

Cox-2 Inhibitors: A Role in Colorectal Cancer?

Published on: January 1, 1999
Result type: Reports

Tags

Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Colorectal Neoplasms, Drug Therapy, Risk Factors, Costs and Cost Analysis, COX-2 Inhibitors, Anti-Inflammatories, NSAIDs, Colon Cancer, Colorectal Cancer, Anti-Inflammatory Agents, Non-Steroidal, Colorectal cancer, Non-Steroidal, Inhibiteur cyclooxygénase, Antiinflammatoires nonstéroïdiens, Tumeur colorectale, Chimiothérapie, Facteur risque, Coût et analyse coût, Inhibiteurs de la COX-2, Anti-inflammatoires, AINS, Cancer du col

Assessment of Attention Deficit/ Hyperactivity Disorder: A Canadian Perspective

Published on: January 1, 1999
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Shukla VK, Otten N. Assessment of attention deficit/hyperactivity disorder therapy: A Canadian perspective. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. The Issues Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neuropsychiatric disorder in children in North America...

Tags

Attention Deficit Disorder with Hyperactivity, Methylphenidate, Central Nervous System Stimulants, Drug Evaluation, Meta-Analysis, Ritalin, Mental Health, Mental health, ADD, ADDH, ADHD, MPH, Trouble déficitaire attention avec hyperactivité, Analeptiques, Évaluation medicament, Méta-analyse, TDAH, TDA, HADA

Economic Evaluation of Erythropoietin Use in Surgery

Published on: October 1, 1998
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

The Issue The use of allogeneic (donor) blood transfusion is associated with risks such as the transmission of infectious diseases including HIV and Hepatitis B and C. The perioperative use of blood in elective surgery (e.g. hip arthroplasty and open heart surgery) accounts for a substantial amount of all blood used. The drug erythropoietin (EPO...

Tags

Hormone, Cost Analysis, Erythropoietin, Evaluation, Blood, Surgery, EPO, Hip replacement, Open heart surgery, Blood banking, Economic, Érythropoïétine, Arthroplastie hanche, Interventions chirurgie cardiaque, Transfusion sanguine autologue, EPO, Prothèse totale hanche, Chirurgie cardiaque, Évaluation économique, Réserves de sang

A Clinical and Economic Review of HMG-CoA Reductase Inhibitors in Coronary Heart Disease

Published on: March 1, 1998
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Abnormalities in blood lipid levels, such as decreased high density lipoprotein (HDL) and elevated total cholesterol (TC), triglycerides (TG), low density lipoproteins (LDLs), very low density lipoproteins and TC/HDL ratios, have been linked to an increase in the risk of developing coronary heart disease (CHD). Pharmacological interventions aime...

Tags

Coronary Disease, Hypercholesterolemia, Drug Therapy, Risk Factors, Cost-Benefit Analysis, HMG-CoA Reductase Inhibitors, Cholesterol, Hydroxmethylglutaryl-CoA Reductase Inhibitors, Statins, CHD, Heart disease, Inhibiteurs hydroxymethylglutaryl-CoA réductase, Vaisseaux coronaries, maladies, Hypercholestérolémie, Chimiothérapie, Facteur risqué, Analyse coût benefice, Statines, Inhibiteurs de l’HMG-CoA réductase, Maladie cardiovasculaire, Cardiopathie

Comparison of Drug Treatments for Multiple Sclerosis

Published on: January 1, 1998
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Otten N. Comparison of drug treatments for multiple sclerosis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998. This rapid assessment brings together the major studies involving the four drugs available in various countries for the treatment of MS: Avonex® (interferon beta 1-a), Rebif® (interferon be...

Tags

Multiple Sclerosis, Interferon-beta, Peptides, Cost-Benefit Analysis, Treatment Outcome, Drug Therapy, beta-Interferon, Multiple sclerosis, Sclérose en plaques, MS, Economic, Interféron type I recombinant, Analyse coût bénéfice, Évaluation resultants traitement, Chimiothérapie, SEP, Interféron bêta-1b, Calcul des coûts

Low molecular weight heparins for major orthopedic surgery: a case for clinical outcomes

Published on: January 1, 1998
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Shukla VK, Otten N. Low molecular weight heparins for major orthopedic surgery: a case for clinical outcomes. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998. The Issue Total hip or knee replacement with artificial joints (arthroplasty) are common surgical procedures. In Ontario alone (1996/97), ther...

Tags

Heparin, Warfarin, Anticoagulants, Arthroplasty, Hip, Knee, Venous Thrombosis, Pulmonary Embolism, LMWH, Heparin, Low-Molecular-Weight, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Surgery, Low-Molecular-Weight, Replacement, Hip replacement, Knee replacement, Héparine bas poids moléculaire, Warfarine, Arthroplastie hanche, Arthroplastie genou, Thrombose veineuse, Embolie pulmonaire, HBPM, Prothèse totale hanche, Prothèse totale genou

Abdominal aortic aneurysm: endovascular grafts offer a potential alternative to surgery

Published on: January 1, 1998
Result type: Reports

Tags

Aortic Aneurysm, Blood Vessel Prosthesis Implantation, Vascular Surgical Procedures, Postoperative Complications, Treatment Outcome, Costs and Cost Analysis, Aneurysm, Blood Vessel Prosthesis, Stents, Aortic Aneurysm, Abdominal, Medical devices, Abdominal, Endovascular grafts, Vascular surgery, Anévrysme aorte abdominale, Implantation prothèse vasculaire, Intervention chirurgicale vasculaire, Complications postopératoires, Évaluation resultants traitement, Coût et analyse coût, Anévrisme, Greffons prothétiques intravasculaires, Mise en place prothèse vasculaire, Chirurgie vasculaire, Chirurgie vasculaire

A review of therapies for attention-deficit/hyperactivity disorder

Published on: January 1, 1998
Result type: Reports

Cite as: Miller A, Lee S, Raina P, Klassen A, Zupancic J, Olsen L. A review of therapies for attention-deficit/hyperactivity disorder. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. This is a report to the Canadian Coordinating Office for Health Technology Assessment which summarizes work completed between ...

Tags

Methylphenidate, Learning Disorders, Attention Deficit Hyperactivity Disorder, Learning disorder, ADD, ADDH, ADHD, MPH, Metaanalysis, Trouble déficitaire attention avec hyperactivité, Analeptiques, Méta-analyse, TDAH, TDA, HADA,

Economic evaluation comparing low molecular weight heparin with other modalities for the prevention of deep vein thrombosis and pulmonary embolism following total hip or knee arthroplasty

Published on: January 1, 1998
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Anderson D, O'Brien B, Nagpal S. et al. Economic evaluation comparing low molecular weight heparin with other modalities for the prevention of deep vein thrombosis and pulmonary embolism following total hip or knee arthroplasty. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998. Deep vein thrombosis is...

Tags

Heparin, Warfarin, Anticoagulants, Venous Thrombosis, Pulmonary Embolism, Arthroplasty, Hip, Knee, LMWH, Thrombosis, Heparin, Low-Molecular-Weight, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Surgery, Thrombosis, Low-Molecular-Weight, Replacement, Hip replacement, Knee replacement, Héparine bas poids moléculaire, Warfarine, Thrombose veineuse, Embolie pulmonaire, Arthroplastie hanche, Arthroplastie genou, HBPM, Prothèse totale hanche, Prothèse totale genou